These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30770073)

  • 1. Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction.
    Khan S; Amjad A; Rowland D
    J Sex Med; 2019 Feb; 16(2):300-306. PubMed ID: 30770073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.
    Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP
    J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral therapy as an adjunct treatment for Pakistani men with ED.
    Khan S; Amjad A; Rowland D
    Int J Impot Res; 2017 Sep; 29(5):202-206. PubMed ID: 28701798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?
    McCabe MP; Althof SE
    J Sex Med; 2014 Feb; 11(2):347-63. PubMed ID: 24251371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.
    Munk NE; Knudsen JS; Comerma-Steffensen S; Simonsen U
    Sex Med Rev; 2019 Jul; 7(3):430-441. PubMed ID: 30711478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care.
    Costa P; Grandmottet G; Mai HD; Droupy S
    J Sex Med; 2013 Jul; 10(7):1850-60. PubMed ID: 23679019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment.
    Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M
    J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HelpED study: agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with erectile dysfunction and their partners.
    Claes HI; Andrianne R; Opsomer R; Albert A; Patel S; Commers K
    J Sex Med; 2012 Oct; 9(10):2652-63. PubMed ID: 22906210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-Based Group Therapy for Men With Situational Erectile Dysfunction: A Mixed-Methods Feasibility Analysis and Pilot Study.
    Bossio JA; Basson R; Driscoll M; Correia S; Brotto LA
    J Sex Med; 2018 Oct; 15(10):1478-1490. PubMed ID: 30297094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
    Srini VS; Reddy RK; Shultz T; Denes B
    Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men.
    Lee DM; Nazroo J; Pendleton N
    Int J Impot Res; 2015 Jul; 27(4):146-51. PubMed ID: 25809698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
    Kitrey ND; Gruenwald I; Appel B; Shechter A; Massarwa O; Vardi Y
    J Urol; 2016 May; 195(5):1550-1555. PubMed ID: 26694904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily.
    Burns PR; Rosen RC; Dunn M; Baygani SK; Perelman MA
    J Sex Med; 2015 Mar; 12(3):720-7. PubMed ID: 25615445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Couples' reasons for adherence to, or discontinuation of, PDE type 5 inhibitors for men with erectile dysfunction at 12 to 24-month follow-up after a 6-month free trial.
    Conaglen HM; Conaglen JV
    J Sex Med; 2012 Mar; 9(3):857-65. PubMed ID: 22239731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction.
    Fisher WA; Rosen RC; Eardley I; Niederberger C; Nadel A; Kaufman J; Sand M
    J Sex Med; 2004 Sep; 1(2):150-60. PubMed ID: 16422969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
    Cai Z; Zhang J; Li H
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
    El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
    Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.